EV/EBITDA:
-12.99+0.08(+0.61%)Summary
- As of today (July 1, 2025), APLS EV/EBITDA is -12.99, with a rise of +0.08 (+0.61%) during the most recent trading session on June 30, 2025.
- Over the past year, APLS EV/EBITDA has increased by +3.14 (+19.47%).
- APLS EV/EBITDA is now -261.84% below its all-time high of -3.59.
Performance
APLS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APLS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +0.6% | -0.7% | -0.7% |
| 1 m1 month | -2.1% | +2.1% | +2.2% |
| 3 m3 months | - | - | -28.7% |
| 6 m6 months | +33.6% | -44.3% | -45.7% |
| ytdytd | +51.3% | -44.6% | -45.8% |
| 1 y1 year | +19.5% | -52.5% | -54.9% |
| 5 y5 years | -134.9% | -9.0% | -47.0% |
APLS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -12.72 | -2.1% | -14.61 | +11.1% |
| 3 m | 3-month | -12.31 | -5.5% | -15.15 | +14.3% |
| 6 m | 6-month | -12.31 | -5.5% | -28.33 | +54.1% |
| 1 y | 1-year | -12.31 | -5.5% | -28.33 | +54.1% |
| 3 y | 3-year | -3.59 | -261.8% | -28.33 | +54.1% |
| 5 y | 5-year | -3.59 | -261.8% | -28.33 | +54.1% |
| alltime | all time | -3.59 | -261.8% | -28.33 | +54.1% |
APLS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -12.99(-51.3%) |
| 2024 | -26.69(+91.1%) |
| 2023 | -13.97(+63.0%) |
| 2022 | -8.57(+49.8%) |
| Date | Value |
|---|---|
| 2021 | -5.72(-57.1%) |
| 2020 | -13.34(+126.1%) |
| 2019 | -5.90(+23.7%) |
| 2018 | -4.77(-74.4%) |
| 2017 | -18.62 |
FAQ
- What is Apellis Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Apellis Pharmaceuticals?
- What is APLS EV/EBITDA year-to-date change?
- What is Apellis Pharmaceuticals EV/EBITDA year-on-year change?
What is Apellis Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of APLS is -12.99
What is the all time high EV/EBITDA for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high EV/EBITDA is -3.59
What is APLS EV/EBITDA year-to-date change?
Apellis Pharmaceuticals EV/EBITDA has changed by +13.70 (+51.33%) since the beginning of the year
What is Apellis Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, APLS EV/EBITDA has changed by +3.14 (+19.47%)